Effect of Nasal Continuous Positive Airway Pressure on Infants With Meconium Aspiration Syndrome
Author(s) -
Aakash Pandita,
Srinivas Murki,
Tejo Pratap Oleti,
Baswaraj Tandur,
Sai Kiran,
Sachin B. Narkhede,
Amrut Prajapati
Publication year - 2017
Publication title -
jama pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.004
H-Index - 183
eISSN - 2168-6211
pISSN - 2168-6203
DOI - 10.1001/jamapediatrics.2017.3873
Subject(s) - medicine , continuous positive airway pressure , respiratory distress , meconium aspiration syndrome , randomized controlled trial , neonatal intensive care unit , fraction of inspired oxygen , gestational age , intensive care , positive airway pressure , anesthesia , retinopathy of prematurity , mechanical ventilation , atelectasis , positive pressure , mean airway pressure , amniotic fluid , bronchopulmonary dysplasia , pediatrics , meconium , pregnancy , lung , surgery , intensive care medicine , fetus , biology , obstructive sleep apnea , genetics
Nasal continuous positive airway pressure (NCPAP) as a primary respiratory therapy in meconium aspiration syndrome (MAS) has not been studied extensively. Nasal continuous positive airway pressure, when applied in newborns with MAS, may resolve atelectasis by sufficiently expanding partially obstructed small airways and stabilizing the collapsing terminal airways to enhance oxygen exchange.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom